Free Trial

Brokerages Set Plexus Corp. (NASDAQ:PLXS) PT at $152.00

Plexus logo with Computer and Technology background

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Plexus Corp. (NASDAQ:PLXS - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the five research firms that are currently covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $152.00.

A number of brokerages have issued reports on PLXS. Needham & Company LLC reduced their price objective on shares of Plexus from $162.00 to $158.00 and set a "buy" rating for the company in a research report on Thursday, July 24th. Sidoti raised shares of Plexus from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $135.00 to $150.00 in a research report on Friday, July 25th. Benchmark reaffirmed a "buy" rating and issued a $160.00 price objective on shares of Plexus in a research report on Wednesday, June 4th. Wall Street Zen downgraded shares of Plexus from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 16th. Finally, Stifel Nicolaus set a $140.00 price objective on shares of Plexus in a research report on Thursday, July 24th.

Get Our Latest Report on PLXS

Plexus Trading Up 5.1%

Shares of Plexus stock traded up $6.71 during trading on Tuesday, hitting $137.26. The company's stock had a trading volume of 151,618 shares, compared to its average volume of 179,689. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.58 and a quick ratio of 0.74. Plexus has a 52 week low of $103.43 and a 52 week high of $172.89. The stock has a market cap of $3.70 billion, a price-to-earnings ratio of 23.38 and a beta of 0.80. The stock has a 50-day moving average price of $132.30 and a two-hundred day moving average price of $130.17.

Plexus (NASDAQ:PLXS - Get Free Report) last issued its quarterly earnings results on Wednesday, July 23rd. The technology company reported $1.90 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.19. Plexus had a net margin of 4.04% and a return on equity of 12.33%. The business had revenue of $1.02 billion for the quarter, compared to analysts' expectations of $1.02 billion. During the same quarter in the prior year, the firm posted $1.45 earnings per share. The business's quarterly revenue was up 6.0% compared to the same quarter last year. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. Equities research analysts anticipate that Plexus will post 5.9 EPS for the current fiscal year.

Insider Buying and Selling

In other Plexus news, insider Michael J. Running sold 646 shares of the stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $130.05, for a total value of $84,012.30. Following the sale, the insider directly owned 630 shares in the company, valued at $81,931.50. This represents a 50.63% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Todd P. Kelsey sold 2,000 shares of the stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $131.68, for a total transaction of $263,360.00. Following the completion of the sale, the chief executive officer owned 76,714 shares in the company, valued at $10,101,699.52. This represents a 2.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 12,484 shares of company stock worth $1,626,335 in the last 90 days. 1.76% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of PLXS. Fuller & Thaler Asset Management Inc. boosted its stake in shares of Plexus by 120.4% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 348,510 shares of the technology company's stock valued at $44,655,000 after purchasing an additional 190,360 shares in the last quarter. Nuveen LLC bought a new stake in shares of Plexus during the 1st quarter valued at about $22,975,000. GAMMA Investing LLC boosted its stake in shares of Plexus by 19,069.1% during the 1st quarter. GAMMA Investing LLC now owns 170,797 shares of the technology company's stock valued at $21,884,000 after purchasing an additional 169,906 shares in the last quarter. American Century Companies Inc. boosted its stake in shares of Plexus by 24.7% during the 1st quarter. American Century Companies Inc. now owns 678,222 shares of the technology company's stock valued at $86,901,000 after purchasing an additional 134,205 shares in the last quarter. Finally, Millennium Management LLC boosted its stake in shares of Plexus by 85.1% during the 1st quarter. Millennium Management LLC now owns 228,116 shares of the technology company's stock valued at $29,229,000 after purchasing an additional 104,904 shares in the last quarter. Hedge funds and other institutional investors own 94.45% of the company's stock.

About Plexus

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

See Also

Analyst Recommendations for Plexus (NASDAQ:PLXS)

Should You Invest $1,000 in Plexus Right Now?

Before you consider Plexus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.

While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines